Translating Research Into Practice
Effects of Aspirin on Colorectal Cancer Related to Lynch Syndrome
Sarah Leilani Beck, MS, FNP-BC, PCNP
From Binghamton Gastroenterology Associates, Binghamton, New York
The author has no conflicts of interest to disclose.
Correspondence to: Sarah Leilani Beck, MS, FNP-BC, PCNP, Binghamton Gastroenterology Associates, 40 Mitchell Avenue, 3rd floor, Binghamton, NY 13903. E-mail: firstname.lastname@example.org
J Adv Pract Oncol 2012;3:395–398 |
DOI: 10.6004/jadpro.2012.3.6.6 |
© 2012 Harborside Press®
This article is a review of “Long-term effects of aspirin on cancer risk in carriers of hereditary colorectal cancer: An analysis from the CAPP2 randomised controlled trial” by Burn et al. (2011), Lancet, 378, 2081–2087. For another perspective on the Burn et al. article as well as a discussion of challenges faced when interpreting a large prospective trial, please see the related article by Rita Wickham.
For access to the full length article, please sign in